• Research
• Back to Medicine
• Divisions
• Allergy and Inflammation
• Cardiovascular Medicine
• Center for Vascular Biology Research
• Center for Virology and Vaccine Research
• Clinical Informatics
• Clinical Nutrition
• Endocrinology
• Experimental Medicine
• Gastroenterology
• Division of General Medicine and Primary Care Section for Research
• Genetics
• Gerontology
• Hematology-Oncology Research
  • Biologic Therapy (Kidney Cancer and Melanoma) Research
  • Bone Marrow Transplantation Research
  • Breast Cancer Research
  • Cell Growth Regulation and Cancer Biology Research
  • Cellular & Molecular Biology of Hematopoiesis
  • Gastrointestinal Cancer Research
  • Genitourinary Oncology
  • Lung Cancer Research
  • Ovarian Cancer Research
  • Phase I Investigational Group
  • Research Faculty List
  • Laboratories
• Hemostasis and Thrombosis
• Immunology
• Infectious Disease
• Interdisciplinary Medicine and Biotechnology
• Matrix Biology
• Molecular and Vascular Medicine
• Nephrology
• Pulmonary, Critical Care and Sleep Medicine
• Rheumatology
• Signal Transduction
• Translational Research
• Transplant Immunology

Hematology-Oncology Research

The Hematology-Oncology Division of the Cancer Center at BIDMC participates in six of the National Cancer Institute (NCI)-sponsored Specialized Programs in Research Excellence (SPORE) Grants at the Dana-Farber/Harvard Cancer Center (DF/HCC), including lung, prostate, breast, ovarian, skin and kidney. Many of the Division's investigators hold National Institutes of Health (NIH)-sponsored R01 grants.

Research Programs in the division of Hematology/Oncology include:

• Angiogenesis
• Epithelial Malignancies
• Hematopoiesis
• Immunobiology
• Signal Transduction